| Date Filed | Type | Description |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 5,640 options to buy
@ $35.46, valued at
$200k
|
|
| 07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 8,772 options to buy
@ $36.05, valued at
$316.2k
|
|
| 06/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2020 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 390 options to buy
@ $76.94, valued at
$30k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2019 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Blackstone Group Inc|
Txns:
| Granted 4,566 shares
@ $0 |
|
| 07/02/2019 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 343 options to buy
@ $83.85, valued at
$28.8k
|
|
| 06/04/2019 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 2,336 options to buy
@ $79.21, valued at
$185k
|
|
| 04/02/2019 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 346 options to buy
@ $83.17, valued at
$28.7k
|
|
| 01/03/2019 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 376 options to buy
@ $76.41, valued at
$28.8k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2018 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Blackstone Group L.P.|
Txns:
| Granted 4,247 LP units
@ $0 |
|
| 07/02/2018 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 474 options to buy
@ $60.7, valued at
$28.8k
|
|
| 05/29/2018 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 3,131 options to buy
@ $59.09, valued at
$185k
|
|
| 04/03/2018 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 540 options to buy
@ $53.27, valued at
$28.8k
|
|
| 04/02/2018 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on GENERAL ELECTRIC CO|
Txns:
| Granted 5,512 options to buy
@ $14.06, valued at
$77.5k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2016 |
4
| LAZARUS ROCHELLE B (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 20,000 shares
@ $59.06, valued at
$1.2M
Exercised 5,000 options to buy
@ $51.86, valued at
$259.3k
Exercised 5,000 options to buy
@ $38.04, valued at
$190.2k
Exercised 5,000 options to buy
@ $24.3, valued at
$121.5k
Exercised 5,000 options to buy
@ $35.19, valued at
$176k
|
|
|